Skip to main content
. Author manuscript; available in PMC: 2019 Jan 2.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2011 Sep 13;15(2):170–176. doi: 10.1038/pcan.2011.43

Table 3.

Population-based studies of BPH prevalence in African Americans, vs current studya

Reference Population Year Community-based Exclusions at outset
Years of
accrual
Definition of BPH
Prostate cancer Prostate surgery IPSS8
Sarma et al,7 Flint Michigan—369 blacks 2003 Y Y Y 1996 50–59: 41.7%
60–69: 51.1%
70–79: 40.0%
Overall: 44.8%b
Glasser et al,11 USA—596 blacks 2007 Y N N 2001–2002 Overall: 26.4%c
Markland et al,10 San Antonio—355 blacks 2007 N Y N 2001–2006 50–59: 34%
60–69: 33%
70–79: 57%
Overall: 36.3%b
Kupelian et al,17 Boston—1770 blacks aged 30–79 2006 Y Y Y 2002–2005 Overall: 19.3%d
Current study Accra, Ghana—950 West Africans 2009 Y Y N 2004–2006 50–59: 14.8%
60–69: 22.7%
70–74: 34.7%
Overall: 19.9%b

Abbreviation: IPSS, International Prostate Symptom Score.

a

Includes population-based studies reporting IPSS⩾8.

b

Overall estimates standardized to the 2000 World Health Organization world standard population for men aged 50–74 years.

c

Overall estimates are not age standardized; data to standardize not presented.

d

Overall estimates are age standardized to the US 2000 Census for specified age grouping.